about
An update on antibody-based immunotherapies for Clostridium difficile infectionThe potential for emerging therapeutic options for Clostridium difficile infectionRecombinant Clostridium difficile toxin fragments as carrier protein for PSII surface polysaccharide preserve their neutralizing activityA Clostridium difficile Cell Wall Glycopolymer Locus Influences Bacterial Shape, Polysaccharide Production and Virulence.Clostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen.Clostridium difficile infection in the twenty-first century.Overview of Clostridium difficile infection: implications for ChinaVaccines against Clostridium difficile.Immune-based treatment and prevention of Clostridium difficile infection.A Review of the Safety and Efficacy of Vaccines as Prophylaxis for Clostridium difficile Infections.The Design of a Clostridium difficile Carbohydrate-Based Vaccine.Glycan arrays containing synthetic Clostridium difficile lipoteichoic acid oligomers as tools toward a carbohydrate vaccine.Total Synthesis of Five Lipoteichoic acids of Clostridium difficile.Investigating the candidacy of a lipoteichoic acid-based glycoconjugate as a vaccine to combat Clostridium difficile infection.Addressing the global need to combat multidrug resistance: carbohydrates may hold the key.Adaptive immune constraints on C. difficile vaccination.Clostridioides difficile Biology: Sporulation, Germination, and Corresponding Therapies for C. difficile Infection.
P2860
Q26740788-C1F18E0C-0A36-48CA-BBB3-15C005918556Q28082059-2215827E-7E58-4B93-97BE-6D845DDDDAEEQ33584866-E8719B30-2502-4EBD-BB38-C697D3DC8BFCQ36163997-E2BA8698-5FB4-471D-82A8-90994D6DC057Q36190012-0FBAF192-5DB1-44F8-848C-2692C849B034Q37289567-2A94CBD8-AE69-43B1-8113-CFEC6CDCD43FQ37609133-80649A96-AA40-425C-8B01-DD327A0025E4Q38196682-8AA4CE5D-2BA9-4C7D-A6E9-006588DCE1F3Q38350907-F255AA3F-F0B6-4175-B0C7-724A1FD160BFQ40068051-35CC0595-4BBD-45F4-B9E4-BF300E786698Q40715739-E6E86828-4D31-4AA7-9CB7-97E6E25DD045Q42710354-7DC9D0DF-6F68-48D5-A31E-0AAC8AB64AC8Q46846094-E32ABFD5-A038-4705-9B9F-6250417318DBQ47707104-A7952B14-859B-40CA-A040-E5EAD77E28B6Q48723015-95251E06-5D62-489B-99E0-918DC7BB86D1Q50130012-C99206CE-2DC8-416D-8EB6-0D17820EFBBBQ54267984-E42EBE69-B858-490A-848F-424D92C58D35
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Carbohydrate-based Clostridium difficile vaccines.
@en
type
label
Carbohydrate-based Clostridium difficile vaccines.
@en
prefLabel
Carbohydrate-based Clostridium difficile vaccines.
@en
P2093
P2860
P356
P1476
Carbohydrate-based Clostridium difficile vaccines.
@en
P2093
Douglas Hodgins
Gayatri Vedantam
Herbert Chow
John Sundsmo
Lisa Bertolo
Luis Arroyo
Mario A Monteiro
Martin Sagermann
Michael Mallozzi
Yuening Jiao
P2860
P304
P356
10.1586/ERV.13.9
P577
2013-04-01T00:00:00Z